Guanidinopropionic acid
Guanidinopropionic acid | |
---|---|
IUPAC name 3-Carbamimidamidopropanoic acid[1] | |
Other names 3-(Diaminomethylideneamino)propanoic acid[citation needed] | |
Identifiers | |
CAS number | 353-09-3 |
PubChem | 67701 |
ChemSpider | 61020 |
EC number | 206-530-0 |
KEGG | C03065 |
MeSH | guanidopropionic+acid |
ChEBI | CHEBI:15968 |
ChEMBL | CHEMBL20489 |
RTECS number | AY3157500 |
Beilstein Reference | 1705262 |
3DMet | B00534 |
Jmol-3D images | {{#if:[nH]:c(:[nH2]):[nH]CCc(:[o]):[oH]NC(=N)NCCC(O)=O|Image 1 Image 2 |
| |
| |
Properties | |
Molecular formula | C4H9N3O2 |
Molar mass | 131.13 g mol−1 |
Appearance | White crystals |
Odor | Odourless |
log P | −1.472 |
Acidity (pKa) | 4.219 |
Basicity (pKb) | 9.778 |
Hazards | |
GHS pictograms | |
GHS signal word | WARNING |
GHS hazard statements | H315, H319, H335 |
GHS precautionary statements | P261, P305+351+338 |
EU classification | Xi |
R-phrases | R36/37/38 |
S-phrases | S26, S36 |
Related compounds | |
Related alkanoic acids | |
Related compounds | Dimethylacetamide |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
β-Guanidinopropionic acid, also referred to as guanidinopropionic acid, beta-guanidinopropionic acid or β-GPA, is a dietary supplement.
β-Guanidinopropionic acid is a white crystalline powder soluble in water (50 mg/ml-clear, colorless solution).[2]
Studies on animals (rats, monkeys, hamsters) show that acidic guanidine derivatives such as β-GPA can ameliorate hyperglycemia in animal models of noninsulin-dependent diabetes.[3]
Though the oral availability of β-GPA is well established, the basic uptake mechanism has not been studied yet.[4]
References
- ↑ "3-guanidinopropanoic acid (CHEBI:15968)". Chemical Entities of Biological Interest. UK: European Bioinformatics Institute. 20 July2010. Main. Retrieved 26 April 2012.
- ↑ Bergeron, R.; Ren, J. M.; Cadman, K. S.; Moore, I. K.; Perret, P.; Pypaert, M.; Young, L. H.; Semenkovich, C. F.; Shulman, G. I. (2001). "Chronic Activation of AMP Kinase Results in NRF-1 Activation and Mitochondrial Biogenesis" (pdf). American Journal of Physiology. Endocrinology and Metabolism 281 (6): E1340–E1346. PMID 11701451.
- ↑ Meglasson, M. D.; Wilson, J. M.; Yu, J. H.; Robinson, D. D.; Wyse, B. M.; de Souza, C. J. (September 1993). "Antihyperglycemic Action of Guanidinoalkanoic Acids: 3-Guanidinopropionic Acid Ameliorates Hyperglycemia in Diabetic KKAy and C57BL6Job/ob Mice and Increases Glucose Disappearance in Rhesus Monkeys". The Journal of Pharmacology and Experimental Therapeutics 266 (3): 1454–1462. PMID 8371149.
- ↑ Metzner, L.; Dorn, M.; Markwardt, F.; Brandsch, M. (April 2009). "The Orally Active Antihyperglycemic Drug β-Guanidinopropionic Acid is Transported by the Human Proton-Coupled Amino Acid Transporter hPAT1". Molecular Pharmaceutics 6 (3): 1006–1011. doi:10.1021/mp9000684. PMID 19358571.